CYP11B2 and adrenal cortex adenoma: Imaging agents for these targets (CXCR-4 and CYP11B2) have the advantage of identifying adrenal adenomas based on the expression/overexpression of targets not generally seen in normal adrenal tissue, and likely have clinical utility for primary aldosteronism detection.